chloroquine has been researched along with mdv 3100 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeVere White, RW; Evans, CP; Gao, AC; Kung, HJ; Lara, PN; Nguyen, HG; Shi, XB; Tilki, D; Yang, JC | 1 |
| Deng, Y; Guo, X; Jiang, C; Lan, T; Lu, J; Saleem, M; Wang, H; Wang, J; Wang, L; Wu, F; Xiong, H; Zhang, Y | 1 |
2 other study(ies) available for chloroquine and mdv 3100
| Article | Year |
|---|---|
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model.
Topics: Androgen Receptor Antagonists; Animals; Autophagy; Benzamides; Cell Line, Tumor; Chloroquine; Clomipramine; Gene Expression Regulation, Neoplastic; Humans; Male; Metformin; Mice; Mice, SCID; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |
Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer.
Topics: Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Benzamides; Cell Line, Tumor; Cell Survival; Chloroquine; Deoxyglucose; Hexokinase; Humans; Male; Mice; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; PTEN Phosphohydrolase; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |